Fortress Biotech, Inc.
FBIO
$1.66
$0.021.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -46.00M | -48.51M | -40.69M | -54.52M | -60.64M |
| Total Depreciation and Amortization | 4.46M | 4.53M | 4.77M | 4.75M | 6.00M |
| Total Amortization of Deferred Charges | 2.05M | 2.26M | 2.53M | 3.00M | 3.03M |
| Total Other Non-Cash Items | -32.59M | -39.95M | -41.60M | -50.62M | -64.10M |
| Change in Net Operating Assets | -8.13M | -20.55M | -23.94M | -13.00M | -12.52M |
| Cash from Operations | -80.19M | -102.22M | -98.94M | -110.39M | -128.23M |
| Capital Expenditure | -- | -28.00K | -29.00K | -63.00K | -63.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 6.00M | 6.00M | 6.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.00M | -35.00K | -1.04M | -3.04M | -8.04M |
| Cash from Investing | -15.00M | -63.00K | 4.94M | 2.90M | -2.10M |
| Total Debt Issued | 43.67M | 53.20M | 19.53M | 14.53M | 42.53M |
| Total Debt Repaid | -1.25M | -534.00K | -10.91M | -54.38M | -82.32M |
| Issuance of Common Stock | 24.50M | 33.12M | 26.07M | 26.80M | 24.80M |
| Repurchase of Common Stock | -2.27M | -2.27M | -2.27M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -400.00K | -400.00K | -400.00K | -400.00K |
| Total Dividends Paid | -4.02M | -6.02M | -8.03M | -8.03M | -8.03M |
| Other Financing Activities | 10.01M | 11.37M | 59.08M | 59.89M | 56.17M |
| Cash from Financing | 70.64M | 88.45M | 83.06M | 38.41M | 32.74M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.55M | -13.83M | -10.95M | -69.08M | -97.59M |